Developments in X-Ray Tomography XIV 2022
DOI: 10.1117/12.2627682
|View full text |Cite
|
Sign up to set email alerts
|

Neodymium acetate as a contrast agent for x-ray phase-contrast tomography

Abstract: X-ray phase-contrast tomography (XPCT) is a non-destructive, threedimensional imaging modality that provides higher contrast in soft tissue than absorption-based CT and allows one to cover the cytoarchitecture from the centi-and millimeter scale down to the nanoscale. To further increase contrast and resolution of XPCT, for example, in view of addressing connectivity issues in the central nervous system (CNS), metal staining is indispensable. However, currently used protocols, for example, based on osmium and/… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 41 publications
0
4
0
Order By: Relevance
“…can provide ground truth for such algorithm development. While providing good contrast, heavy-metal stains might in fact not be ideal for X-ray imaging and materials with similar dissipation butsignificantly reduced absorption (Busse et al, 2021;Reichmann et al, 2023) might further improve sample stability.…”
Section: Discussionmentioning
confidence: 99%
“…can provide ground truth for such algorithm development. While providing good contrast, heavy-metal stains might in fact not be ideal for X-ray imaging and materials with similar dissipation butsignificantly reduced absorption (Busse et al, 2021;Reichmann et al, 2023) might further improve sample stability.…”
Section: Discussionmentioning
confidence: 99%
“…It was published in the corresponding conference proceedings (SPIE Optics and Photonics 2022: Developments in X-Ray Tomography XIV). 48 Apart from that, there are no relevant financial interests in the paper and no other potential conflicts of interest to disclose.…”
Section: Disclosuresmentioning
confidence: 99%
“…An earlier version of this work was presented at SPIE Optics and Photonics 2022 as contribution 12242-3 “Neodymium acetate as a contrast agent for X-ray phase-contrast tomography” (presentation date: August 22, 2022). It was published in the corresponding conference proceedings (SPIE Optics and Photonics 2022: Developments in X-Ray Tomography XIV) 48 . Apart from that, there are no relevant financial interests in the paper and no other potential conflicts of interest to disclose.…”
Section: Disclosuresmentioning
confidence: 99%
“…Note High-Resolution Neuroimaging by XPCT that the diameter of the biopsy punches would clearly allow a reduction of E by at least a factor of two. Future extension of this work may also include recently developed X-ray stains [32][33][34][35] to improve contrast not only for distinct structural hallmarks of neurodegeneration covered in this work, but also for the individual cellular components e.g. axons, dendrites or synapses, or the myelin sheath which would open up a new perspective for X-ray imaging of myelin-associated diseases, such as multiple sclerosis.…”
Section: Quantitative Comparison Of Electron Densitiesmentioning
confidence: 99%